Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lower dose dexamethasone premedication for docetaxel hypersensitivity prevention
TCTR20230713001Phase 3Completed
- Sponsor
- Chulalongkorn University
- Start
- Jun 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexamethasone in cancer, sponsored by Chulalongkorn University. Started Jun 2023; status: completed.
02
Drugs
dexamethasone
03
Conditions
cancer
Beyond the preview
Go deeper on TCTR20230713001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230713001.